Objectives-Ultrasound-guided thrombin injection has become standard treatment for extremity pseudoaneurysms. Our specific aims were to determine the procedural success rate, the procedural complication rate, and the factors associated with pseudoaneurysm recurrence.
A pseudoaneurysm is an extravascular collection of blood that forms from a defect in an arterial wall. Although surrounding soft tissue contains the extravasated blood, communication with the vessel persists, and blood continues to circulate through the pseudoaneurysm. The formation of a pseudoaneurysm requires focal damage to the vessel wall, which can occur secondary to trauma or, more commonly, after an interventional procedure. A wide variety of interventional radiologic and interventional cardiologic procedures require vascular access, which is frequently achieved through an arterial puncture. If adequate hemostasis is not achieved after a procedure, blood may flow out of the vessel at the puncture site into the surrounding soft tissues, forming a pseudoaneurysm. A pseudoaneurysm is recognized sonographically as an anechoic structure projecting from a vessel, with color Doppler imaging showing a "yin-yang" pattern of color flow in the cavity and to-and-fro blood flow in the neck of the pseudoaneurysm.
Although pseudoaneurysms are contained structures, they are at risk for acute rupture and are associated with hemodynamic compromise. Additionally, they can cause pain, swelling, overlying skin ischemia, and compression of nearby structures. [1] [2] [3] Therefore, pseudoaneurysms require close follow-up to ensure thrombosis and avoid complications. Pseudoaneurysms that persist are subject to treatment. Treatment options include surgical closure of the vascular defect after evacuation of the blood-filled pseudoaneurysm sac. Alternatively, ultrasound-guided compression of the pseudoaneurysm neck may be performed to obliterate flow from the artery into the pseudoaneurysm. 3 However, ultrasound-guided compression is a timeconsuming and potentially painful procedure, with reported success rates ranging from 63% to 88%. 4 Injection of thrombin into the pseudoaneurysm cavity is a third treatment option that has proven to be an effective and rapid therapy for the repair of pseudoaneurysms. Thrombin is a serine protease that catalyzes several coagulation-related reactions as part of the natural human coagulation cascade, including the final step in the cascade, the cleavage of fibrinogen into fibrin. 5, 6 Recombinant thrombin is also commercially available. Ultrasound-guided injection of recombinant thrombin into the pseudoaneurysm sac to achieve pseudoaneurysm thrombosis is an off-label procedure that has become standard treatment for extremity pseudoaneurysms. A 2016 systematic review and meta-analysis by Kontopodis et al 2 concluded that ultrasound-guided thrombin injection is significantly more efficacious than ultrasound-guided compression, and both are equally safe.
Although a number of additional studies have demonstrated ultrasound-guided thrombin injection to be both safe and efficacious, [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] most have been conducted with relatively small sample sizes, and few have focused on the need for follow-up imaging or described the factors associated with pseudoaneurysm recurrence. The purpose of this study was to review cases of ultrasoundguided thrombin injection of pseudoaneurysms performed over a 10-year period to determine the procedural success rate, the procedural complication rate, the rate of pseudoaneurysm recurrence, and the factors associated with failure of complete and sustained pseudoaneurysm thrombosis to be able to recommend appropriate follow-up imaging.
Materials and Methods

Study Design and Approval
The Institutional Review Board granted approval for this retrospective study, and the need for informed consent was waived.
Patients
Consecutive cases of ultrasound-guided thrombin repair of pseudoaneurysm were identified over a 10-year period between January 1, 2006, and March 20, 2016 . Patients included in the analysis had a diagnosis of a pseudoaneurysm, underwent thrombin injection of the pseudoaneurysm under ultrasound guidance, and underwent a subsequent follow-up ultrasound examination to confirm persistent thrombosis or to identify pseudoaneurysm recurrence. Patients in whom there was incomplete pseudoaneurysm thrombosis at the time of thrombin injection were included in the analysis of the procedural success rate and procedural complication rate but were excluded from the analysis of the factors contributing to postprocedural pseudoaneurysm recurrence, as recurrence could not be assessed in patients whose pseudoaneurysms had never primarily resolved. For each individual included in the study, age and sex were recorded.
Ultrasound-Guided Thrombin Injection
Pseudoaneurysms were initially diagnosed by examination with grayscale, color, and spectral Doppler ultrasound. All thrombin injections were performed as the standard of care, and informed consent was obtained before the procedure. Five thousand units of thrombin were diluted in 5 mL of normal saline to yield a concentration of 1000 U/mL. The amount of thrombin injected was recorded for each study. The rate of thrombin injection was at the discretion of the practitioner. All ultrasound-guided thrombin injections were performed by a radiologist or by a vascular surgeon with image guidance provided by the radiology department.
Imaging and Procedural Data
The procedural and follow-up ultrasound studies were reviewed. For each individual included in the study, the following imaging and procedural characteristics were recorded: pseudoaneurysm size (recorded as greatest dimension), pseudoaneurysm complexity (recorded as number of locules), pseudoaneurysm location, amount of thrombin injected, and procedural outcome.
Laboratory Data
For each individual included in the study, the following laboratory characteristics were recorded: white blood cell (WBC) count, hemoglobin, hematocrit, platelet count, prothrombin time (PT), partial thromboplastin time (PTT), international normalized ratio (INR), random glucose, creatinine, and albumin. Laboratory results obtained closest to the date of the thrombin injection (within 3 months; median time, 2 days; interquartile range [IQR], 4 days) were recorded.
Statistical Analysis
Statistical analysis was performed with Stata version 13 software (StataCorp, College Station, TX). The procedural outcome was analyzed as a categorical variable coded as procedural success versus procedural failure. Procedural success was defined as complete thrombosis at the time of injection and on a follow-up examination. Procedural failure was defined as incomplete thrombosis at the time of injection or the presence of flow within the pseudoaneurysm sac on the follow-up ultrasound examination. Pseudoaneurysm location was analyzed as a categorical variable coded as typical location (arising in the groin, which is the site of arterial puncture for most endovascular interventions) versus atypical location (arising in any location other than the groin). Pseudoaneurysm complexity was analyzed as both a categorical variable, coded as a unilocular pseudoaneurysm versus a multilocular pseudoaneurysm, and as a continuous variable, coded as the number of pseudoaneurysm locules. Pseudoaneurysm size was analyzed as a categorical variable coded as greatest dimension of smaller than 2 cm versus greatest dimension of 2 cm or larger. The amount of thrombin injected was analyzed as a continuous variable measured in international units. The WBC count, PT, PTT, INR, and creatinine were analyzed as categorical variables coded as normal versus elevated, and hemoglobin, hematocrit, platelets, and albumin were analyzed as categorical variables coded as normal versus low. Normal laboratory values were based on the standards used by the authors' institution (normal values: WBCs, 10.5 K/lL; PT, 13.0 seconds; PTT, 36.5 seconds; INR, 1.16; creatinine, 1.3 mg/dL; hemoglobin, 11.5 g/dL; hematocrit, 34.5%; platelets, 150 K/ lL, and albumin, 3.3 g/dL). Serum glucose was analyzed as a categorical variable coded as normal versus elevated based on the American Diabetes Association criteria for diagnosing diabetes by random plasma glucose (normal value, < 200 mg/dL). 20 Comparisons of means of continuous variables between procedural successes versus pseudoaneurysm recurrences were performed by the unpaired Student t test or the MannWhitney test, as appropriate. Comparisons of categorical variables between these groups were performed by the v 2 test or the Fisher exact test, as appropriate. Multivariate logistic regression analysis with the binary outcome of procedural success versus postprocedural pseudoaneurysm recurrence was performed. Those variables with P < .10 on bivariate analysis were included in the model. Statistical significance was present with P < .05.
The success rate was calculated as the number of procedural successes divided by the total number of procedures. The complication rate, considered separately from the analyses described above, was calculated as the number of complications divided by the total number of procedures.
Results
In the specified 10-year period, 262 cases of ultrasoundguided thrombin injection of pseudoaneurysms were identified. All pseudoaneurysms were iatrogenic (n5 261) or traumatic (n 5 1). Figure 1 summarizes the number of procedures performed by year. Table 1 summarizes the locations of the treated pseudoaneurysms, 96.9% of which arose from arteries in the groin. Of these 262 cases, 32 were lost to follow-up and were excluded.
The procedural success rate was calculated in the remaining 230 cases, with procedural success occurring in 197 of 230 cases (85.7%). Procedural failures included 8 incompletely thrombosed pseudoaneurysms (3.5%) and 25 postprocedural recurrent pseudoaneurysms (10.9%). It is noteworthy that repeated ultrasoundguided thrombin injection was attempted in 12 recurrent pseudoaneurysms and in 2 incompletely thrombosed pseudoaneurysms, and reinjection was successful in all 14 cases.
Complications, which were considered separately, occurred in 7 of 230 cases (3.0%). Three complications occurred in successful cases and 4 in recurrent cases and included intravascular thrombus formation (n 5 5) and infection (n 5 2).
Patients in whom there was incomplete pseudoaneurysm thrombosis at the time of thrombin injection (n 5 8) were excluded from the following analysis of the factors contributing to postprocedural pseudoaneurysm recurrence, as recurrence could not be assessed in patients whose pseudoaneurysms had never primarily resolved. Therefore, the analysis of postprocedural pseudoaneurysm recurrence included the remaining 222 cases of ultrasound-guided thrombin injection performed in 220 patients, 48.6% of whom were male. Patients had a mean age 6 SD of 72.3 6 11.3 years. The median pseudoaneurysm size as measured by greatest dimension was 2.3 cm (IQR, 1.2 cm). The complexity of the injected pseudoaneurysms, as measured by the number of locules, is summarized in Table 2 . The median thrombin injected during the procedure was 500 U (IQR, 400 U). The median time to the first follow-up ultrasound examination after the ultrasound-guided thrombin injection procedure was 1 day (IQR, 0 days).
Results of bivariate analyses comparing 197 successful cases of ultrasound-guided thrombin injection and 25 cases of pseudoaneurysm recurrence after ultrasound- a Pseudoaneurysm locations are provided for all 262 procedures performed during the specified period, before exclusion of those patients who were lost to follow-up or in whom complete thrombosis was not achieved. Groin pseudoaneurysms include those arising from the external iliac, common femoral, superficial femoral, and deep femoral arteries. guided thrombin injection are presented in Table 3 . The proportion of those patients with pseudoaneurysms of 2 cm or larger in the greatest dimension was significantly higher in recurrent cases compared to successful cases (96.0% versus 67.6%; P 5 .003). Similarly, the proportion of those patients with thrombocytopenia was significantly greater in recurrent cases compared to successful cases (45.0% versus 22.2%; P 5 .03). However, there was no significant association between pseudoaneurysm recurrence and patient age, sex, amount of thrombin injected, atypical pseudoaneurysm location, pseudoaneurysm complexity/number of pseudoaneurysm locules, leukocytosis, anemia, coagulopathy, renal failure, hyperglycemia, or hypoalbuminemia. Table 4 summarizes the results of the multivariate logistic regression analysis. Both a large pseudoaneurysm size and the presence of thrombocytopenia were significant independent predictors of pseudoaneurysm recurrence after ultrasound-guided thrombin injection. A pseudoaneurysm size of 2 cm or larger increased the odds of recurrence by 229% (P 5 .03) compared to a pseudoaneurysm size of less than 2 cm. Thrombocytopenia increased the odds of recurrence by 4% (P 5 .04) compared to the presence of normal platelet levels.
Discussion
Thrombin injection of pseudoaneurysms is less invasive than surgical repair and is more efficacious, less painful, and less time-consuming than manual compression with an ultrasound transducer, with thrombosis occurring within 3 to 60 seconds of thrombin injection. 8, 15, 21 In this 10-year retrospective study, we found that ultrasound-guided thrombin injection of pseudoaneurysms had a success rate of 85.7%, with a postprocedural recurrence rate of 10.9% and a rate of incomplete thrombosis at the time of thrombin injection of 3.5%. The complication rate, considered separately, was 3.0%. These results are concordant with those in prior studies, which suggest that ultrasound-guided thrombin injection is a relatively effective and safe treatment. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] It is noteworthy that no immediate complications were identified in the 32 patients who were excluded from this study for loss to follow-up. This finding suggests that the complication rate reported in this study is a conservative estimate. Similarly, complete pseudoaneurysm thrombosis was achieved in all 32 patients who were excluded from the analysis due to lack of follow-up examinations. None of these patients presented subsequently to our institution with symptoms suggesting pseudoaneurysm recurrence. This finding again suggests that the procedural success rate reported in this study is a conservative estimate.
It is important to note that in cases of both incomplete pseudoaneurysm thrombosis and postprocedural pseudoaneurysm recurrence, repeated thrombin injection may be attempted at the discretion of the provider. In this study, repeated ultrasound-guided thrombin injection was attempted in 12 of the 25 recurrent pseudoaneurysms and in 2 of the 8 incompletely thrombosed pseudoaneurysms. Complete pseudoaneurysm thrombosis was achieved in 100% of these reinjections.
Furthermore, the results of this study demonstrate that pseudoaneurysms that are 2 cm or larger in the greatest dimension are independently predictive of pseudoaneurysm recurrence. The odds of observing pseudoaneurysm recurrence are greater than 2-fold higher when the pseudoaneurysm is 2 cm or larger in the greatest dimension. In smaller studies of 32 and 121 patients, Olsen et al 22 and Chen et al 1 found no association between pseudoaneurysm size and successful thrombosis. However, this discordance in results may have been due to differences in statistical power. This study also demonstrated that thrombocytopenia is a significant independent predictor of pseudoaneurysm recurrence, with 4% increased odds of pseudoaneurysm recurrence in patients with thrombocytopenia. Interestingly, none of the other individual parameters that would typically be used in the assessment of coagulation function, including PT, PTT, and INR, were associated with procedural success or pseudoaneurysm recurrence in this study. Although other studies by Olsen et al, 22 Chen et al, 1 and Schneider et al 21 have suggested that anticoagulation and antiplatelet therapy do not prevent successful pseudoaneurysm thrombosis, Madaric et al 23 found that combined antiplatelet and anticoagulation therapy increased the odds of pseudoaneurysm recurrence by greater than 2-fold.
Olsen et al 22 also found that successful pseudoaneurysm thrombosis was independent of the amount or concentration of thrombin injected. Similarly, this study demonstrated no significant association between the amount of thrombin injected and pseudoaneurysm recurrence. Although both studies imply that thrombosis can be achieved with lower thrombin concentrations, it is important to note that this study was not designed to determine the most appropriate thrombin concentration to be used in a given case.
Chen et al, 1 Krueger et al, 24 and Kr€ uger et al 25 found greater rates of initial incomplete thrombosis with complex relative to simple pseudoaneurysms; however, the association between complexity and postprocedural pseudoaneurysm recurrence was not assessed in those prior studies. This study found no significant association between complex versus simple pseudoaneurysms with regard to postprocedural recurrence or between the number of pseudoaneurysm locules and postprocedural recurrence. Interestingly, despite the known vasculopathic effects of diabetes, hyperglycemia diagnostic of diabetes (per the American Diabetes Association criteria) 20 was not significantly associated with postprocedural pseudoaneurysm recurrence. The inflammatory milieu characterized by leukocytosis, which might have been expected to increase the rate of successful thrombosis and decrease the rate of recurrence, 26 similarly demonstrated no significant association with the procedural outcome. This study had several limitations. It was a retrospective study. As the study extended back for 10 years, there were cases in which data were unavailable. Furthermore, although the study analyzed cases from over the past decade, only short-term follow-up was obtained. Late pseudoaneurysm recurrences or late complications occurring subsequent to the initial follow-up ultrasound examinations and presentations to an outside hospital could not be evaluated. However, a prior prospective study with a longer follow-up time averaging 11.8 months found no late recurrences, only identifying several early recurrences that would have been identified in this study. 22 As is the case with any procedure, success is largely determined by the experience and skill of the practitioner. This study was conducted within a single health care system, meaning that all of the procedures described in this study were performed by a limited group of practitioners; therefore, results are not necessarily generalizable. Although this study had a large sample size compared to prior similar studies, the sample size in this study is considered relatively small in comparison to typical epidemiologic studies. Last, although we report a complication rate and conservatively include all complications that could be attributed to thrombin injection, it is not possible to determine whether certain complications that we report as being secondary to thrombin injection (such as infection and intravascular thrombosis) are actually secondary to the other endovascular procedure performed at the site of the pseudoaneurysm or secondary to the prolonged inactivity and bed rest typically required after any endovascular procedure.
In conclusion, over a greater than 10-year period, ultrasound-guided thrombin injection of pseudoaneurysms was shown to have a success rate of 85.7%, a recurrence rate of 10.9%, and a complication rate of only 3.0%. Pseudoaneurysms that are 2 cm or larger in the greatest dimension and thrombocytopenia are significant independent predictors of postprocedural pseudoaneurysm recurrence. Based on these findings, short-interval follow-up imaging is recommended in all pseudoaneurysms that are 2 cm or larger in the greatest dimension and in patients with thrombocytopenia.
